These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 5405840)

  • 1. [Rifampicin in the treatment of pulmonary tuberculosis].
    Daddi G; Lucchesi M; Rossi P; Sbampato M
    Ann Ist Carlo Forlanini; 1969; 29(1):3-16. PubMed ID: 5405840
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined treatment with rifampicin-ethambutol-capreomycin in chronic open pulmonary tuberculosis.
    Virchow C; Flemming J
    Acta Tuberc Pneumol Belg; 1969; 60(3):466-70. PubMed ID: 5371671
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of intractable pulmonary tuberculosis: place of capreomycin in therapeutic programs with rifampicin and ethambutol].
    Oury M; Tuchais E; Norval C; Carbonnelle B; Leroux MF; Corre C; Parvery F
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):519-30. PubMed ID: 5510321
    [No Abstract]   [Full Text] [Related]  

  • 4. [Place of rifampicin in the treatment of pulmonary tuberculosis].
    Despierres G; Bonnet PA; Phélip H
    J Med Lyon; 1971 Jun; 52(210):893-4 passim. PubMed ID: 5132687
    [No Abstract]   [Full Text] [Related]  

  • 5. [The therapeutic action of Rifampicin, a derivative of 3-(4-methyl-1-piperazinyl-iminomethyl)-rifamycin SV, in pulmonary tuberculosis].
    Lucchesi M; Pallotta G; Rossi P; Sbampato M
    Ann Ist Carlo Forlanini; 1967; 27(3):199-227. PubMed ID: 5602885
    [No Abstract]   [Full Text] [Related]  

  • 6. [Late results of treatment of chronic pulmonary tuberculosis with rifampicin].
    Lachowicz E; Polaczek E; Araszkiewicz W; Kozakow H; Pszonicka A; Styszewska H; Janowiec M; Grabowska R
    Gruzlica; 1973 Jul; 41(7):781-7. PubMed ID: 4730979
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preliminary clinical observations on the use of Rifampicin in chronic cavitary pulmonary tuberculosis previously treated with and resistant to other drugs].
    Mauro G
    Arch Tisiol Mal Appar Respir; 1968 Jun; 23(6):461-6. PubMed ID: 5309059
    [No Abstract]   [Full Text] [Related]  

  • 8. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection.
    Yu WC; Lai ST; Chiu MC; Chau TN; Ng TK; Tam CM
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):824-5. PubMed ID: 16850548
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combination therapy with butomelide and rifampicin in experimental tuberculosis in albino mice].
    Pershin GN; Zykova TN; Kutchak SN
    Probl Tuberk; 1977 Jan; (1):64-9. PubMed ID: 834763
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of chronic tuberculosis patients with ethambutol and protoionamide combined with rifampicin and capreomicin].
    Grassi C; Cornia G; Cirianni C; Garimoldi M; Ginesu F; Mandler F; Perna G; Pradella F
    G Ital Chemioter; 1968; 15(4):92-4. PubMed ID: 5744843
    [No Abstract]   [Full Text] [Related]  

  • 11. Rifampin and other drugs for treatment of tuberculosis.
    Med Lett Drugs Ther; 1971 Sep; 13(18):73-4. PubMed ID: 5122869
    [No Abstract]   [Full Text] [Related]  

  • 12. [Corrective possibilities of rifampicin in ineffective chemotherapy of destructive pulmonary tuberculosis in children and adolescents].
    Ivaniuta OM; Il'nitskiĭ IG; Panasiuk AV; Kunichkina SA
    Probl Tuberk; 1987; (8):30-3. PubMed ID: 3684986
    [No Abstract]   [Full Text] [Related]  

  • 13. Widespread distribution of a single drug rifampicin formulation of inferior bioavailability in South Africa.
    Bhaduri J
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1128-9; author reply 1129. PubMed ID: 12546124
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of treatment with rifampicin in 39 patients hospitalized in our service during 1970-1971-1972].
    Maalej M; Chabbou A; Zbiba M; El Gharbi B; Halfon S; El Gharbi T; Cheniti M; El Mekki L; Djen Ayah F; Chebbi ML; Jeguirim M; Ben Salah M
    Tunis Med; 1974; 52(6):313-6. PubMed ID: 4619937
    [No Abstract]   [Full Text] [Related]  

  • 15. The advantages of the antituberculosis regimens which include Sinerdol-EH, a new tuberculostatic of rifampicin-type.
    Păunescu E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(1):33-42. PubMed ID: 6312533
    [No Abstract]   [Full Text] [Related]  

  • 16. Rifampin in the treatment of drug-resistant TB.
    Vall-Spinosa A; Lester W; Moulding T; Davidson PT; McClatchy JK
    Md State Med J; 1971 Jun; 20(6):79-80. PubMed ID: 5141742
    [No Abstract]   [Full Text] [Related]  

  • 17. [A role of the biological chip test in the determination of rifampicin resistance in Mycobacteria in adolescents with active pulmonary tuberculosis].
    Firsova VA; Poluektova FG; Kuz'min AV; Chernousova LN
    Probl Tuberk Bolezn Legk; 2004; (8):28-30. PubMed ID: 15478555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On a new class of bactericidal antibiotics with special reference to rifampicin].
    Kradolfer F
    Schweiz Med Wochenschr; 1968 Apr; 98(16):622-7. PubMed ID: 5688592
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study on rifomycin in resumption of treatment of pulmonary tuberculosis cases with polyresistant bacilli].
    Prignot J; Gyselen A; Cosemans J; De Brabandere R; Verbist L; Simon-Pouthier F
    Acta Tuberc Pneumol Belg; 1969; 60(3):487-95. PubMed ID: 4906102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.